Drupal.behaviors.print = function(context) {window.print();window.close();}>
Asuragen, Life Technologies Ink MDx Alliance
November 18, 2009
Asuragen, Life Technologies Ink MDx Alliance
By a GenomeWeb staff reporter
Asuragen will seek FDA clearance for the CML test, which Life Technologies will distribute.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Life Tech Investing $18M to Expand Facility to Achieve cGMP Capabilities
March 28, 2013 / GenomeWeb Daily News
FDA Clears Quidel C. difficile Assay for Life Tech's QuantStudio Dx and 7500 Fast Dx PCR Instruments
March 18, 2013 / GenomeWeb Daily News
Exosome Diagnostics, Life Technologies Ink Agreement for Oncology Dx Program
June 4, 2012 / GenomeWeb Daily News
Finnish Team Develops Multiple Heat Pulse PCR Method for Amplification of GC-Rich Regions
January 19, 2012 / PCR Insider
Life Tech Receives AFNOR Certification for Listeria Assays
January 5, 2012 / GenomeWeb Daily News